Tarrytown, New York, Jan. 08, 2026 (GLOBE NEWSWIRE) — ENT & Allergy Associates, the nation's largest ENT, allergy, and audiology practice, is pleased to announce that Evan Sarti, D.O., a board-certified otolaryngologist and facial plastic surgeon, will join the practice on February 1, 2026 at its new, state-of-the-art clinical location in Morristown, New Jersey. Dr. […]

ABU DHABI, United Arab Emirates, Jan. 08, 2026 (GLOBE NEWSWIRE) — The ADI Foundation has partnered with M-Pesa Africa to extend blockchain infrastructure to the platform's 60+ million monthly users. The partnership outlines a framework for deploying ADI Chain across eight African countries where M-Pesa currently operates. The partnership will connect M-Pesa's user base across

(Helsinki:ORNBV), ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE) Orion Corporation (Orion Pharma) announces initiation of a Phase 2 trial evaluating ODM-212, a potential best-in-class, oral pan-TEAD inhibitor, as a monotherapy in

— Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of AGMB-447 in healthy participants — — Pharmacokinetic profile in healthy participants shows low systemic exposure of AGMB-447, with high exposure to the lung — — Robust dose-dependent target engagement of ALK5 observed

VICTORIA, Seychelles, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bitget, the world's largest Universal Exchange (UEX), has recorded more than $2 billion in daily trading volume on Bitget TradFi, marking a major milestone since its public rollout on January 5. The performance highlights accelerating demand for access to traditional markets on the platform as a hedge

Fortuna reports progress on its share buyback program GlobeNewswire January 08, 2026 VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to report that, from Tuesday, December 23, 2025, through Wednesday, January 7, 2026, the Company repurchased an aggregate of 1,700,000 common shares on the

New Crypto Mutuum Finance (MUTM) Nears Roadmap Major Milestone Following Halborn Security Review GlobeNewswire January 08, 2026 DUBAI, United Arab Emirates, Jan. 08, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project developing a decentralized lending and borrowing protocol, has shared updates tied to its product roadmap after reporting the completion of an

ADI Foundation Partners with M-Pesa to Bring 60+ Million Mobile Money Platform Users Onchain MENA's First Institutional L2 partners with Africa's Leading Mobile Payment Service, Expanding Blockchain Access Across Eight Markets GlobeNewswire January 08, 2026 ABU DHABI, United Arab Emirates, Jan. 08, 2026 (GLOBE NEWSWIRE) — The ADI Foundation has partnered with M-Pesa Africa to

Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE) GlobeNewswire January 08, 2026 ORION CORPORATION PRESS RELEASE 8 JANUARY 2026 at 12.00 EET Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma

Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort GlobeNewswire January 08, 2026 — Interim data from Phase 1 with single and multiple ascending doses show no safety signals and a generally favorable tolerability profile of AGMB-447 in healthy participants — — Pharmacokinetic profile in